DIAGNOSIS, PROGNOSIS, AND STANDARD TREATMENT OF MULTIPLE MYELOMA
- 1 February 1997
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 11 (1), 111-131
- https://doi.org/10.1016/s0889-8588(05)70418-4
Abstract
No abstract availableKeywords
This publication has 138 references indexed in Scilit:
- A randomized multicentric study comparing alternating combination chemotherapy (VCMP/VBAP) and melphalan-prednisone in multiple myelomaBlut: Zeitschrift für die Gesamte Blutforschung, 1990
- VAD‐based regimens as primary treatment for multiple myelomaAmerican Journal of Hematology, 1990
- INFUSION OF VINCRISTINE AND DOXORUBICIN WITH ORAL DEXAMETHASONE AS FIRST-LINE THERAPY FOR MULTIPLE MYELOMAThe Lancet, 1989
- Is aggressive chemotherapy more effective in the treatment of plasma cell myeloma?European Journal of Cancer and Clinical Oncology, 1989
- Induction and maintenance therapy in multiple myeloma: a multicenter trial of MP versus VCMPEuropean Journal of Cancer and Clinical Oncology, 1988
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- Treatment of multiple myeloma with M-2 protocol and without maintenance therapyEuropean Journal of Cancer and Clinical Oncology, 1983
- Bence Jones Proteins: Malignant or Benign?New England Journal of Medicine, 1982
- The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute LeukemiaNew England Journal of Medicine, 1979
- Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimensJAMA, 1969